Clinical Trial Update: Addressing Treatment Nonresponders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial at the University of Arizona aimed at addressing treatment nonresponders in developmental language disorders. The study status is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Language Disorder

Snippet

Sponsor: University of Arizona | Conditions: Language Development Disorders | Phase 2 | Status: NOT_YET_RECRUITING